About Satyadeeptha Pharmaceuticals
Satyadeeptha Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 1994 by Surapaneni Ramakrishna. It manufactures high-quality API and pharmaceutical products for various applications. It operates on a B2B model. The company has 166 employees. Its chief executive, as recorded, is Surapaneni Ramakrishna. Its Indian entity Satyadeeptha Pharmaceuticals Limited reported revenue of ₹139 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and API and Pharmaceutical Products. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Satyadeeptha Pharmaceuticals, led by Surapaneni Ramakrishna as Founder, CEO, Managing Director, specializes in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and api and pharmaceutical products. Manufactures high-quality API and pharmaceutical products for various applications. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.
- Headquarters Hyderabad, India
- Employees 166
- Founders Surapaneni Ramakrishna
- SectorsHealthcare
- Website satyadeeptha.com
- Legal Name Satyadeeptha Pharmaceuticals Limited
- Date of Incorporation 10 Mar, 1987
- Jurisdiction Bidar, Karnataka, India
- Annual Revenue₹139 Cr
FY 2025 · -31% YoY
- Net Loss-₹75.5 Lakh
FY 2025 · -1% margin
- EBITDA₹13.64 Cr
FY 2025 · 10% margin
- Employee Count166
Associated legal entities of Satyadeeptha Pharmaceuticals
Satyadeeptha Pharmaceuticals operates through Satyadeeptha Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Satyadeeptha Pharmaceuticals Limited CIN U85110KA1993PLC013900 | Active | 10 Mar 1987 | Humnabad, Karnataka | ₹139 Cr | 166 | 6 | View details |
Board of directors of Satyadeeptha Pharmaceuticals Limited (Satyadeeptha Pharmaceuticals)
Satyadeeptha Pharmaceuticals Limited is the primary company behind Satyadeeptha Pharmaceuticals. The board of Satyadeeptha Pharmaceuticals Limited currently have 6 directors; the longest-serving is Surapaneni Ramakrishna, appointed in 1993. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Surapaneni Ramakrishna DIN 00414395 | Managing Director | 18 Jan 1993 | 33 yrs 9 mo | Satyadeeptha Pharmaceuticals Limited |
| Surapaneni Sarojinidevi DIN 00414406 | Whole-time director | 20 Mar 1999 | 27 yrs 7 mo | Satyadeeptha Pharmaceuticals Limited |
| Prasada Rao Kalluri DIN 07780628 | Director | 25 Sep 2021 | 5 yrs 1 mo | Satyadeeptha Pharmaceuticals Limited |
| Surapaneni Janardhana Rao DIN 08367143 | Whole-time director | 24 Feb 2023 | 3 yrs 8 mo | Satyadeeptha Pharmaceuticals Limited |
| Sudheer Kumar Aleti DIN 10655300 | Director | 30 Sep 2025 | 1 yr 1 mo | Satyadeeptha Pharmaceuticals Limited |
| Mandapakala Neelalohita DIN 11195797 | Director | 30 Sep 2025 | 1 yr 1 mo | Satyadeeptha Pharmaceuticals Limited |
People of Satyadeeptha Pharmaceuticals
1 people are tracked at Satyadeeptha Pharmaceuticals (1 in leadership); the tracked headcount is 166.
| Name | Role | Group |
|---|---|---|
| Founder, CEO, Managing Director | Leadership |
Complete people profiles for Satyadeeptha Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Satyadeeptha Pharmaceuticals
Figures of Satyadeeptha Pharmaceuticals Limited, the primary company behind Satyadeeptha Pharmaceuticals, for FY 2025. Revenue was ₹139 Cr (-31% year on year). Net loss was -₹75.5 Lakh (-1% margin). EBITDA was ₹13.64 Cr (10% margin). Revenue has grown at a compounded annual rate of +11% over three years and -4% over five years.
- ₹139 CrRevenue · FY 2025 · -31% YoY
- -₹75.5 LakhNet loss · -1% margin
- ₹13.64 CrEBITDA · 10% margin
- ₹3.88 CrPaid-up capital
- 166Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- -4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Satyadeeptha Pharmaceuticals Limited are on its company page.
Detailed financial statements for Satyadeeptha Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Satyadeeptha Pharmaceuticals
Satyadeeptha Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Satyadeeptha Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Satyadeeptha Pharmaceuticals
Complete news archive for Satyadeeptha Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satyadeeptha Pharmaceuticals
Satyadeeptha Pharmaceuticals was founded in 1994.
Satyadeeptha Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Surapaneni Ramakrishna is the CEO of Satyadeeptha Pharmaceuticals, as recorded in our data. They have also founded this company.
Satyadeeptha Pharmaceuticals has 166 employees.
The primary company behind Satyadeeptha Pharmaceuticals, Satyadeeptha Pharmaceuticals Limited, reported revenue of ₹139 Cr for FY 2025, down 31% year on year.
Satyadeeptha Pharmaceuticals, led by Surapaneni Ramakrishna as Founder, CEO, Managing Director, specializes in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and api and pharmaceutical products. Manufactures high-quality API and pharmaceutical products for various applications. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.
Satyadeeptha Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and SeQuent.
Satyadeeptha Pharmaceuticals operates through Satyadeeptha Pharmaceuticals Limited.
The legal entities of Satyadeeptha Pharmaceuticals currently have 6 directors, including Prasada Rao Kalluri, Surapaneni Janardhana Rao, Surapaneni Sarojinidevi and others.